journal article·2026-06

MoB MBene Based Nanoplatform for Enhanced Cancer Immunotherapy via cGAS Demethylation and Hypoxia Reversion

Ying Liu, Jiaqing Xu, Xiangchun Liu, Shiye Zhu, Yu Cao

Advanced Functional Materials· Volume 36· Issue 49
Publisher page

Abstract

ABSTRACT The cyclic GMP‐AMP synthase‐stimulator of interferon gene (cGAS‐STING) signaling pathway plays a crucial role in initiating anti‐tumor immunity. However, its activation is usually suppressed due to cGAS methylation. Therefore, in this work, DSPE‐PEG‐RGD modified molybdenum boride (MoB) MBenes were loaded with SUV39H1 inhibitor chaetocin (MoB/Chae.‐RGD) to alleviate the cGAS methylation for enhanced cancer immunotherapy. The prepared MoB/Chae.‐RGD possessed good catalase‐like capacity and photothermal conversion efficiency. Under 1060 nm laser irradiation, the chaetocin would be released to inhibit cGAS methylation and thus enhance the recognition of cytosolic mtDNA resulting from photothermal‐induced mitochondrial stress, eventually amplifying the cGAS‐STING activation. Meanwhile, the photo induced heating could promote the catalase‐like capacity of MoB/Chae.‐RGD for O 2 generation, whereby both relieving hypoxia and TIME via promoting the polarization of macrophages from the M2 to the M1 phenotype. In addition, the photothermal effect could induce the immunogenic cell death and the exposure of damage‐associated molecular patterns, facilitating the infiltration of T lymphocytes and the generation of a long term immune memory. These combined effects contributed to the mobilization of systemic antitumor immunity and the prevention of pulmonary metastasis. In general, this finding provided novel avenues for immunotherapy of the immune “cold” solid tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · interferon and immune responses · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hubei Province Key Laboratory of Biotechnology of Chinese Traditional Medicine, College of Health Science and Engineering Hubei University Wuhan China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Hubei Province

References (44)

Show source-provided references
1. 10.1038/s41577‐023‐00973‐810.1038/s41577‐023‐00973‐8 ↗
2. 10.1038/s41571‐021‐00552‐710.1038/s41571‐021‐00552‐7 ↗
3. 10.1038/s43018‐024‐00730‐310.1038/s43018‐024‐00730‐3 ↗
4. 10.1038/s41586‐024‐07620‐910.1038/s41586‐024‐07620‐9 ↗
5. 10.1021/jacs.3c1400510.1021/jacs.3c14005 ↗
6. 10.1038/s41556‐019‐0299‐010.1038/s41556‐019‐0299‐0 ↗
7. 10.1186/s13045‐022‐01292‐610.1186/s13045‐022‐01292‐6 ↗
8. 10.1021/acsnano.3c0776310.1021/acsnano.3c07763 ↗
9. 10.1038/s41590‐024‐01872‐310.1038/s41590‐024‐01872‐3 ↗
10. 10.1038/s41422‐020‐00395‐410.1038/s41422‐020‐00395‐4 ↗
11. 10.1016/j.xcrm.2024.10179710.1016/j.xcrm.2024.101797 ↗
12. 10.1038/s41556‐023‐01185‐x10.1038/s41556‐023‐01185‐x ↗
13. 10.1038/s41586‐023‐05880‐510.1038/s41586‐023‐05880‐5 ↗
14. 10.1038/s41551‐024‐01194‐710.1038/s41551‐024‐01194‐7 ↗
15. 10.1038/s41551‐024‐01221‐710.1038/s41551‐024‐01221‐7 ↗
16. 10.1021/jacs.4c1255210.1021/jacs.4c12552 ↗
17. 10.1002/anie.20231879910.1002/anie.202318799 ↗
18. 10.1038/s41565‐022‐01225‐x10.1038/s41565‐022‐01225‐x ↗
19. 10.1002/adma.20230017110.1002/adma.202300171 ↗
20. 10.1126/sciadv.aba758910.1126/sciadv.aba7589 ↗
21. 10.1002/adma.20230085410.1002/adma.202300854 ↗
22. 10.1126/science.aba609810.1126/science.aba6098 ↗
23. 10.1126/science.abb425510.1126/science.abb4255 ↗
24. 10.1038/s41551‐024‐01191‐w10.1038/s41551‐024‐01191‐w ↗
25. 10.1002/adma.20241492910.1002/adma.202414929 ↗
26. 10.1002/adma.20220540910.1002/adma.202205409 ↗
27. 10.1002/adma.20241889410.1002/adma.202418894 ↗
28. 10.1002/adfm.20230146210.1002/adfm.202301462 ↗
29. 10.1016/j.ccell.2023.05.00510.1016/j.ccell.2023.05.005 ↗
30. 10.1002/adma.20241436510.1002/adma.202414365 ↗
31. 10.1021/acsnano.4c0548310.1021/acsnano.4c05483 ↗
32. 10.1002/adma.20230085410.1002/adma.202300854 ↗
33. 10.1016/j.freeradbiomed.2021.11.04010.1016/j.freeradbiomed.2021.11.040 ↗
34. 10.1021/acsami.4c0301210.1021/acsami.4c03012 ↗
35. 10.1002/adma.20250118410.1002/adma.202501184 ↗
36. 10.1021/acsnano.1c1073210.1021/acsnano.1c10732 ↗
37. 10.1016/j.cej.2024.15562710.1016/j.cej.2024.155627 ↗
38. 10.1016/j.ensm.2020.07.04010.1016/j.ensm.2020.07.040 ↗
39. 10.1016/j.jallcom.2021.16019210.1016/j.jallcom.2021.160192 ↗
40. 10.1021/acsnano.3c0228710.1021/acsnano.3c02287 ↗
41. 10.1016/j.cell.2014.05.01210.1016/j.cell.2014.05.012 ↗
42. 10.1002/adma.20240497110.1002/adma.202404971 ↗
43. 10.1021/acs.nanolett.2c0089910.1021/acs.nanolett.2c00899 ↗
44. 10.1021/acsnano.2c1089310.1021/acsnano.2c10893 ↗